SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001615774-16-004676
Filing Date
2016-03-30
Accepted
2016-03-30 06:02:27
Documents
3
Period of Report
2016-03-30
Items
Item 2.02: Results of Operations and Financial Condition
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K s102900_8k.htm 8-K 30380
2 EXHIBIT 99.1 s102900_ex99-1.htm EX-99.1 25814
3 GRAPHIC chart.jpg GRAPHIC 45902
  Complete submission text file 0001615774-16-004676.txt   120764
Mailing Address 1617 JFK BLVD, SUITE #500 ONE PENN CENTER PHILADELPHIA PA 19103
Business Address 1617 JFK BLVD, SUITE #500 ONE PENN CENTER PHILADELPHIA PA 19103 215-988-0080
HEMISPHERX BIOPHARMA INC (Filer) CIK: 0000946644 (see all company filings)

IRS No.: 520845822 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-27072 | Film No.: 161536924
SIC: 2836 Biological Products, (No Diagnostic Substances)